当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 现金流量表

同和药业

(300636)

  

流通市值:26.60亿  总市值:30.40亿
流通股本:3.67亿   总股本:4.20亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金163,052,924.02749,491,411.77543,433,426.58381,438,529.86
  收到的税费返还23,407,529.653,679,946.9943,912,759.623,285,732.81
  收到其他与经营活动有关的现金7,824,213.9326,966,162.5120,499,825.6916,032,247.44
  经营活动现金流入小计194,284,667.55830,137,521.27607,846,011.87420,756,510.11
  购买商品、接受劳务支付的现金97,708,069.04414,309,194.97249,430,115.46181,547,559.23
  支付给职工以及为职工支付的现金56,772,888.48177,700,710.71132,058,780.2288,526,309.91
  支付的各项税费1,264,573.457,130,309.235,801,175.474,298,917.48
  支付其他与经营活动有关的现金16,076,481.6828,926,568.8527,374,325.5818,568,016.26
  经营活动现金流出小计171,822,012.65628,066,783.76414,664,396.73292,940,802.88
  经营活动产生的现金流量净额22,462,654.9202,070,737.51193,181,615.14127,815,707.23
二、投资活动产生的现金流量:
  收回投资收到的现金164,103,194.45599,278,710.77466,708,181.12366,022,044.1
  取得投资收益收到的现金107,243.84367,655.14144,159.55106,263.77
  处置固定资产、无形资产和其他长期资产收回的现金净额67,081.06391,656.81365,027.45365,027.45
  投资活动现金流入小计164,277,519.35600,038,022.72467,217,368.12366,493,335.32
  购建固定资产、无形资产和其他长期资产支付的现金58,450,699.09291,242,885.75282,238,078.23185,032,228.44
  投资支付的现金239,747,123.3325,703,888.9153,337,916.6711,000,000
  投资活动现金流出小计298,197,822.39616,946,774.65435,575,994.9196,032,228.44
  投资活动产生的现金流量净额-133,920,303.04-16,908,751.9331,641,373.22170,461,106.88
三、筹资活动产生的现金流量:
  取得借款收到的现金59,712,000459,890,512.13348,014,762.13222,580,000
  收到其他与筹资活动有关的现金-10,000,00010,000,00010,000,000
  筹资活动现金流入小计59,712,000469,890,512.13358,014,762.13232,580,000
  偿还债务支付的现金83,847,309.13525,620,000467,120,000302,040,000
  分配股利、利润或偿付利息支付的现金2,631,324.7828,778,546.9925,823,508.8123,039,781.89
  支付其他与筹资活动有关的现金185,541.813,456,481.114,173,575.613,895,262.9
  筹资活动现金流出小计86,664,175.71567,855,028.09507,117,084.41338,975,044.79
  筹资活动产生的现金流量净额-26,952,175.71-97,964,515.96-149,102,322.28-106,395,044.79
四、汇率变动对现金及现金等价物的影响-4,187,012.02233,576.11,405,439.241,613,697.98
五、现金及现金等价物净增加额-142,596,835.8787,431,045.7277,126,105.32193,495,467.3
  加:期初现金及现金等价物余额252,843,283.48165,412,237.76165,412,237.76165,412,237.76
  期末现金及现金等价物余额110,246,447.61252,843,283.48242,538,343.08358,907,705.06
补充资料:
  净利润-73,091,433.31-58,486,512.57
  资产减值准备-63,655,296.94-27,567,589.48
  固定资产和投资性房地产折旧-129,453,490-67,063,005.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-129,453,490-67,063,005.24
  无形资产摊销-866,186.24-346,466.15
  长期待摊费用摊销-509,569.02--
  处置固定资产、无形资产和其他长期资产的损失-767,628.83-194,305.92
  公允价值变动损失--214,316.67--
  财务费用-12,413,025.03-861,276.29
  投资损失-1,116,706.88--13,865.51
  递延所得税-2,259,244.38-5,595,892.79
  其中:递延所得税资产减少-11,079,513.84-10,059,036.23
    递延所得税负债增加--8,820,269.46--4,463,143.44
  存货的减少--20,125,235.98--4,558,272.49
  经营性应收项目的减少--37,197,879.57--27,409,323.7
  经营性应付项目的增加-31,454,595.14--1,117,328.59
  其他--56,827,874.04-375,015.08
  现金的期末余额-252,843,283.48-358,907,705.06
  减:现金的期初余额-165,412,237.76-165,412,237.76
  现金及现金等价物的净增加额-87,431,045.72-193,495,467.3
公告日期2026-04-292026-04-292025-10-252025-08-29
审计意见(境内)标准无保留意见
TOP↑